Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
During 1985–1990 the U.S. National Cancer Institute (NCI) phased out its murine leukemia P388 anticancer drug screening program and developed as the replacement a new in vitro primary screen based upon a diverse panel of human tumor cell lines. For each substance tested, the screen generates a remarkably reproducible and characteristic profile of differential in vitro cellular sensitivity, or lack thereof, across the 60 different cell lines comprising the panel. Several investigational approaches to display, analysis, and interpretation of such profiles and databases, derived from the testing of tens of thousands of substances during the past 4–5 years since the NCI screen became fully operational, have been explored. A variety of useful, practical applications of the in vitro screen have become apparent. As these applications continue to evolve, they are proving to be complementary to diverse other anticancer screening and drug discovery strategies being developed or pursued elsewhere. Reviewed herein are some practical considerations and selected specific examples, particularly illustrating research applications of the NCI screen that may be more broadly applicable to the search for new anticancer drug development leads with novel profiles of antitumor activity and/or mechanisms of action. © 1995 Wiley‐Liss, Inc. This article is a US Government work and, as such, is in the public domain in the United States of America.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in December 1992, MDA‐MB‐435 was added to the NCI‐60 cell line panel for use in anticancer drug screening, where it was initially described as a “breast” cancer cell line.17”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [17]
Citations
Cites
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
Self-citationMonks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.11.757 · Cited by 3,289
Self-citationA Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
Soule, H. D., Vazquez, J., Long, A., Albert, S., & Brennan, M. (1973) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1409 · Cited by 2,449
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
Kaighn, M. E., Ks, N., Ohnuki, Y., Lechner, J. F., & Jones, L. W. (1979) · PubMed · Cited by 2,121
Breast Tumor Cell Lines From Pleural Effusions2
Cailleau, R., Young, R., Olivé, M., & Reeves, W. J. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/53.3.661 · Cited by 1,015
Paull, K. D., Shoemaker, R. H., Hodes, L., Monks, A., Scudiero, D. A., Rubinstein, L., Plowman, J., & Boyd, M. R. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.14.1088 · Cited by 967
Self-citationRubinstein, L. V., Shoemaker, R. H., Paull, K. D., Simon, R. M., Tosini, S., Skehan, P., Scudiero, D. A., Monks, A., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1113 · Cited by 927
Self-citationIsolation of a human prostate carcinoma cell line (DU 145)
Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., & Paulson, D. F. (1978) · International Journal of Cancer · doi:10.1002/ijc.2910210305 · Cited by 926
Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
Cailleau, R., Olivé, M., & Cruciger, Q. V. J. (1978) · In Vitro · doi:10.1007/bf02616120 · Cited by 679
Establishment and characterization of a cell line of human breast carcinoma origin
Keydar, I., Chen, L., Karby, S., Weiss, F. R., Delarea, J., Radu, M., Chaitcik, S., & Brenner, H. J. (1979) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(79)90139-7 · Cited by 650
Research works printed but not linked: 6
- Acton EM, 1992, Anticancer specificity of some ellipticinium salts against human brain tumors in vitro, Proc Am Assoc Cancer Res, 33, 488
- Boyd MR, 1986, Accomplishments in Oncology, Vol 1, Cancer Therapy: Where Do We Go From Here?, 68
- Boyd MR, 1989, Cancer: Principles and Practice of Oncology Updates, 1
- Buolamwini JK, 1994, Searching for new molecular targets for therapy of cancer and AIDS: Characterization by 2D protein gel electrophoresis, Proc Am Assoc Cancer Res, 35, 613
- Grever MR, 1994, Status of in vivo evaluations in the NCI anticancer drug discovery program, Proc Am Assoc Cancer Res, 35, 369
- Stinson SF, 1992, Morphologic and immunocytochemical characteristics of human tumor cell lines for use in an anticancer drug screen, Anticancer Res, 12, 1035
Cited by
Items 701–800 of 1,000
Tawfik, H. O., Belal, A., Abourehab, M. A. S., Angeli, A., Bonardi, A., Supuran, C. T., & El‐Hamamsy, M. H. (2022) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2130285 · Cited by 25
RetractedAbdou, W. M., Ganoub, N. A., & Sabry, E. (2015) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-015-1542-4 · Cited by 25
Das, U., Pati, H. N., Sakagami, H., Hashimoto, K., Kawase, M., Balzarini, J. M., Clercq, E. D., & Dimmock, J. R. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101595p · Cited by 25
Kayarmar, R., Nagaraja, G. K., Naik, P., Manjunatha, H., Revanasiddappa, B. C., & Arulmoli, T. (2014) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2014.07.003 · Cited by 25
Abdou, W. M., Barghash, R. F., & Sediek, A. A. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.09.032 · Cited by 25
Chakrabarti, A., Witsenburg, J. J., Sinzinger, M. D., Richter, M., Wallbrecher, R., Cluitmans, J. C. A., Verdurmen, W. P. R., Tanis, S. E. J., Adjobo-Hermans, M. J. W., Rademann, J., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.08.001 · Cited by 25
ABL kinase inhibitory and antiproliferative activity of novel picolinamide based benzothiazoles
El‐Damasy, A. K., Cho, N., Kang, S. B., Pae, A. N., & Keum, G. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.03.067 · Cited by 25
Braulio Insuasty, O., Chamizo, L., Muñoz, J., Tigreros, A., Jairo Quiroga, P., Abonía, R., Nogueras, M., & Cobo, J. (2011) · Archiv der Pharmazie · doi:10.1002/ardp.201100170 · Cited by 25
Supek, F., Kralj, M., Marjanović, M., Šuman, L., Šmuc, T., Krizmanić, I., & Žinić, M. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9084-1 · Cited by 27
Nikšić, H., Kovač-Bešović, E. E., Omeragić, E., Muratović, S., Kusturica, J., & Durić, K. (2017) · Journal of Health Sciences · doi:10.17532/jhsci.2017.412 · Cited by 25
Newman, D. J., Cragg, G. M. L., & Kingston, D. G. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417205-0.00005-5 · Cited by 35
Characterizing Cancer Drug Response and Biological Correlates: A Geometric Network Approach
Pouryahya, M., Oh, J. H., Mathews, J. C., Deasy, J. O., & Tannenbaum, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-24679-3 · Cited by 25
Yang, L.-M., Lin, S., Hsu, F., & Yang, T.-H. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00092-6 · Cited by 25
Wang, H., HAN, H., Mousses, S., & VonHoff, D. D. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.04.013 · Cited by 33
Searching for Pharmacogenomic Markers: The Synergy between Omic and Hypothesis‐Driven Research
Weinstein, J. N. (2001) · Disease Markers · doi:10.1155/2001/435746 · Cited by 25
Liu, Z., Floss, H. G., Cassady, J. M., & Chan, K. K. (2005) · Journal of Mass Spectrometry · doi:10.1002/jms.800 · Cited by 25
Isolation and characterization of novel cytotoxic saponins from Archidendron ellipticum
Beutler, J. A., Kashman, Y., Pannell, L. K., Cardellina, J. H., Alexander, M., Balaschak, M. S., Prather, T. R., Shoemaker, R. H., & Boyd, M. R. (1997) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(97)00098-9 · Cited by 25
Self-citationAran, J. M., Pastan, I. H., & Gottesman, M. M. (1999) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60468-8 · Cited by 25
Krstulović, L., Špoljarić, K. M., Rastija, V., Filipović, N., Bajić, M., & Glavaš‐Obrovac, L. (2023) · Molecules · doi:10.3390/molecules28196950 · Cited by 24
Chen, Y., Lin, Y., Morris-Natschke, S. L., Wei, C., Shen, T., Lin, H., Hsu, M., Chou, L., Zhao, Y., Kuo, S., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12992 · Cited by 25
Chaaban, I., Khawass, E. S. M. E., Razik, H. A. A. E., Salamouni, N. S. E., Redondo‐Horcajo, M., Barasoaín, I., Díaz, J. F., Yli‐Kauhaluoma, J. T., & Moreira, V. M. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.015 · Cited by 24
Chen, T., Yü, D., Huang, K.-F., Fu, Y.-C., Lee, C.-C., Chen, C., Huang, F.-C., Hsieh, H.-H., Lin, J., & Huang, H. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.06.058 · Cited by 24
Elgazwy, A. S. H., Edrees, M. M., & Ismail, N. S. M. (2012) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.719504 · Cited by 24
Racanè, L., Stojković, R., Tralić‐Kulenović, V., Cerić, H., Đaković, M., Ester, K., Krpan, A. M., & Stojković, M. R. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.08.072 · Cited by 24
Kamble, A. A., Kamble, R. R., Dodamani, S., Jalalpure, S. S., Rasal, V. P., Kumbar, M. N., Joshi, S. D., & Dixit, S. R. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0887-0 · Cited by 24
Zorzanelli, B. C., de Queiroz, L. N., Santos, R. M., Menezes, L. M., Gomes, F. C., Ferreira, V. F., da Silva, F. D. C., & Robbs, B. K. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0205 · Cited by 24
Abdelrahman, M. A., Eldehna, W. M., Nocentini, A., Bua, S., Al‐Rashood, S. T., Hassan, G. S., Bonardi, A., Almehizia, A. A., Alkahtani, H. M., Alharbi, A., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102484 · Cited by 24
Jha, A., Duffield, K. M., Ness, M. R., Ravoori, S., Andrews, G., Bhullar, K. S., Rupasinghe, H. P. V., & Balzarini, J. M. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.08.023 · Cited by 24
Lee, C.-C., Chang, D., Huang, K.-F., Chen, C., Chen, T., Lo, Y., Guh, J., & Huang, H. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.006 · Cited by 24
A novel application of DDQ as electrophile in the Nenitzescu reaction
Kucklaender, U., Bollig, R., Frank, W. C., Gratz, A., & Jose, J. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.006 · Cited by 24
Hu, K., & Yao, X. (2002) · Phytomedicine · doi:10.1078/09447110260573218 · Cited by 24
Novel cytotoxic diterpenes from the stem of dysoxylum kuskusense
Fujioka, T., Yamamoto, M., Kashiwada, Y., Fujii, H., Mihashi, K., Ikeshiro, Y., Chen, I. S., & Lee, K. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00630-1 · Cited by 24
Erickson, K. L., Gustafson, K. R., Milanowski, D. J., Pannell, L. K., Klose, J. R., & Boyd, M. R. (2003) · Tetrahedron · doi:10.1016/j.tet.2003.10.060 · Cited by 24
Self-citationSynthesis and Biological Evaluation of 16E-Arylidenosteroids as Cytotoxic and Anti-aromatase Agents
Bansal, R., Guleria, S., Thota, S., Hartmann, R. W., & Zimmer, C. (2011) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.59.327 · Cited by 29
Conti, P., Roda, G., Stabile, H., Vanoni, M. A., Curti, B., & Amici, M. D. (2003) · Il Farmaco · doi:10.1016/s0014-827x(03)00107-1 · Cited by 24
Karki, S. S., Das, U., Umemura, N., Sakagami, H., Iwamoto, S., Kawase, M., Balzarini, J. M., Clercq, E. D., Dimmock, S. G., & Dimmock, J. R. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01706 · Cited by 24
Parabolic growth patterns in 96-well plate cell growth experiments
Faessel, H. M., Levasseur, L. M., Slocum, H. K., & Greco, W. R. (1999) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-999-0071-z · Cited by 24
Cs�ka, K., Dhar, S., Fridborg, H., Larsson, R., & Nygren, P. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970315)79:6<1225::aid-cncr23>3.0.co;2-0 · Cited by 24
Morcoss, M. M., Abdelhafez, E. M. N., Abdel-Rahman, H. M., Abdel‐Aziz, M., & Ella, D. A. A. E. (2020) · Journal of advanced Biomedical and Pharmaceutical Sciences · doi:10.21608/jabps.2020.21160.1064 · Cited by 23
Rani, S., Gupta, S. K., Luxami, V., & Paul, K. (2022) · New Journal of Chemistry · doi:10.1039/d1nj03650e · Cited by 24
Tiglani, D., Salahuddin, S., Mazumder, A., Kumar, R., Yar, M. S., Ahsan, M. J., & Shabana, K. (2023) · Polycyclic aromatic compounds · doi:10.1080/10406638.2023.2183969 · Cited by 23
Mohamed‐Ezzat, R. A., & Elgemeie, G. H. (2024) · BMC Chemistry · doi:10.1186/s13065-024-01164-9 · Cited by 23
Sheta, Y. S., Sarg, M. T. M., Abdulrahman, F. G., Nossier, E. S., & Husseiny, E. M. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107471 · Cited by 23
Onnis, V., Cocco, M. T., Lilliu, V., & Congiu, C. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.11.069 · Cited by 23
Lim, J. C. W., Jeyaraj, E. J., Sagineedu, S. R., Wong, W. S. F., & Stanslas, J. (2015) · Pharmacology · doi:10.1159/000370313 · Cited by 23
Synthesis and Cytotoxicity of Derivatives of Dipterocarpol, a Metabolite of Dipterocarpus alatus
Huong, D. T. T., Thủy, T. T. T., Hiền, T. T., Tra, N. T., Tien, N. Q., Smirnova, I. E., Kazakova, O. B., Minnibaeva, E. M., & Толстиков, Г. А. (2013) · Chemistry of Natural Compounds · doi:10.1007/s10600-013-0505-4 · Cited by 23
Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides
Raffa, D., Maggio, B., Cascioferro, S., Raimondi, M. V., Schillaci, D., Giorgio, G., Daidone, G., Plescia, S., Meneghetti, F., Bombieri, G., et al. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.03.023 · Cited by 23
Arrowsmith, J., Jennings, S. A., Langnel, D. A. F., Wheelhouse, R. T., & Stevens, M. F. G. (2000) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/b005652i · Cited by 23
Hartley, R., Peng, J., Fest, G. A., Dakshanamurthy, S., Frantz, D. E., Brown, M. L., & Mooberry, S. L. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.075838 · Cited by 23
Synthesis, antitumor screening and cell cycle analysis of novel benzothieno[3,2-b]pyran derivatives
Zaher, A. F., Abuel‐Maaty, S. M., El‐Nassan, H. B., Amer, S. A. S., & Abdelghany, T. M. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1222582 · Cited by 23
Khusnutdinova, E. F., Petrova, A. V., Zileeva, Z. R., Kuzmina, U. S., Зайнуллина, Л. Ф., Vakhitova, Y. V., Babkov, D. A., & Kazakova, O. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189796 · Cited by 25
Habib, N. S., Soliman, R., El‐Tombary, A. A., El-Hawash, S. A., & Shaaban, O. G. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0324-3 · Cited by 23
Ashour, H. M. A., El‐Wakil, M. H., Khalil, M. A., Ismail, K. A., & Labouta, I. M. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0192-x · Cited by 23
Cytotoxic activity of flavone glycoside from the stem of Indigofera aspalathoides Vahl
Balasubramanian, R., Murugesh, N., Kedalgovindaram, L., & Rama, K. D. (2006) · Journal of Natural Medicines · doi:10.1007/s11418-006-0026-6 · Cited by 23
Verma, M., Luxami, V., & Paul, K. (2015) · RSC Advances · doi:10.1039/c5ra00925a · Cited by 23
Antypenko, O., Antypenko, L., Коваленко, С. І., Katsev, A. M., & Achkasova, O. M. (2014) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2014.09.009 · Cited by 23
El-Hawash, S. A., & Wahab, A. E. A. (2006) · Archiv der Pharmazie · doi:10.1002/ardp.200600012 · Cited by 23
Khodair, A. I., & Gesson, J. (1998) · Phosphorus, sulfur, and silicon and the related elements · doi:10.1080/10426509808029674 · Cited by 23
Synthesis and Antitumor Activity of Mechercharmycin A Analogues
Hernández‐Romero, D., Altuna, M., Cuevas, C., Aligué, R., Alberício, F., & Álvarez, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800513w · Cited by 23
El‐Sherbeny, M. A., Abdel‐Aziz, A. A. ‐., & Ahmed, M. A. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.11.014 · Cited by 23
Güzel-Akdemir, Ö., Terzioğlu, N., Çapan, G., & Salman, A. (2006) · ARKIVOC · doi:10.3998/ark.5550190.0007.c12 · Cited by 23
A model-based approach to the in vitro evaluation of anticancer activity
Bene, F. D., Germani, M., Nicolao, G. D., Magni, P., Re, C. E., Ballinari, D., & Rocchetti, M. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0798-3 · Cited by 26
Gonzalez‐Nicolini, V., & Fussenegger, M. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200503000-00001 · Cited by 23
Antineoplastic potency of arylchloroethylurea derivatives in murine colon carcinoma
Miot-Noirault, E., Legault, J., Cachin, F., Mounetou, E., Degoul, F., Gaudreault, R. C., Moins, N., & Madelmont, J. C. (2004) · Investigational New Drugs · doi:10.1023/b:drug.0000036679.12112.4c · Cited by 23
Koike, M., Fujita, F., Komori, K., Katoh, F., Sugimoto, T., Sakamoto, Y., Matsuda, M., & Fujita, M. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03246.x · Cited by 23
El‐Gazzar, Y. I., Ghaiad, H. R., Kerdawy, A. M. E., George, R. F., Georgey, H. H., Youssef, K. M., & El‐Subbagh, H. I. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202200417 · Cited by 22
Eldehna, W. M., Elsayed, Z. M., Ammara, A., Hassab, M. A. E., Almahli, H., Farès, M., Nocentini, A., Supuran, C. T., & Abou‐Seri, S. M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135010 · Cited by 22
Ashour, H. M. A., & Wahab, A. E. A. (2009) · Archiv der Pharmazie · doi:10.1002/ardp.200800178 · Cited by 22
Maggio, B., Raimondi, M. V., Raffa, D., Plescia, F., Cascioferro, S., Plescia, S., Tolomeo, M., Cristina, A. D., Pipitone, R. M., Grimaudo, S., et al. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.10.032 · Cited by 22
Synthesis and Anticancer Activity of N -Aryl-5-substituted-1,3,4-oxadiazol-2-amine Analogues
Ahsan, M. J., Sharma, J., Singh, M., Jadav, S. S., & Yasmin, S. (2014) · BioMed Research International · doi:10.1155/2014/814984 · Cited by 22
Acetophenone Monomers from Acronychia trifoliolata
Miyake, K., Suzuki, A., Morita, C., Goto, M., Newman, D. J., O’Keefe, B. R., Morris-Natschke, S. L., Lee, K., & Nakagawa‐Goto, K. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b00645 · Cited by 22
Avvaru, S. P., Noolvi, M. N., More, U. A., Chakraborty, S., Dash, A. K., Aminabhavi, T. M., Narayan, K. P., & Sutariya, V. (2020) · Medicinal Chemistry · doi:10.2174/1573406416666200519085626 · Cited by 22
Fouad, M. A., Zaki, M. Y., Lotfy, R. A., & Mahmoud, W. R. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104985 · Cited by 22
Maciejewska, D., Wolska, I., Niemyjska, M., & Żero, P. (2005) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2005.05.035 · Cited by 22
Design, synthesis and antiproliferative activity of indole analogues of indanocine
Tunbridge, G. A., Oram, J., & Caggiano, L. (2013) · MedChemComm · doi:10.1039/c3md00200d · Cited by 22
New anti‐tumor agents. 1. Heterocyclic benzodioxole lactones
Jurd, L. (1996) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570330438 · Cited by 22
1,4,9,10-Anthradiquinone as precursor for antitumor compounds
Schenck, L. W., Kuna, K., Frank, W. C., Albert, A., Asche, C., & Kucklaender, U. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.01.026 · Cited by 22
Bis[3,5‐bis(benzylidene)‐4‐oxo‐1‐piperidinyl]amides: A Novel Class of Potent Cytotoxins
Das, S., Das, U., Varela-Ramírez, A., Lema, C., Aguilera, R. J., Balzarini, J. M., Clercq, E. D., Dimmock, S. G., Gorecki, D. K. J., & Dimmock, J. R. (2011) · ChemMedChem · doi:10.1002/cmdc.201100199 · Cited by 22
Faidallah, H. M., Khan, K. A., Rostom, S. A. F., & Asiri, A. M. (2012) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2011.653354 · Cited by 22
Ahsan, M. J. (2013) · Medicinal Chemistry · doi:10.4172/2161-0444.1000154 · Cited by 22
Synthesis and Antiproliferative Activity of Some Quinoline and Oxadiazole Derivatives
Ahsan, M. J., Shastri, S., Yadav, R., Hassan, M. Z., Bakht, M. A., Jadav, S. S., & Yasmin, S. (2016) · Organic Chemistry International · doi:10.1155/2016/9589517 · Cited by 22
DNA-damaging natural products with potential anticancer activity
(1997) · Studies in natural products chemistry · doi:10.1016/s1572-5995(97)80036-1 · Cited by 22
McNally, V. A., Gbaj, A. M., Douglas, K. T., Stratford, I. J., Jaffar, M., Freeman, S., & Bryce, R. A. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.010 · Cited by 22
Bosanquet, A., Burlton, A. R., Bell, P., & Harris, A. L. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.417 · Cited by 22
Huang, R., Wallqvist, A., & Covell, D. G. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051029m · Cited by 22
Shaikh, N. H., Maheta, J. B., Lakhnotra, D. K., Ram, I. M., Bhola, Y. O., & Jain, S. A. (2025) · ChemistrySelect · doi:10.1002/slct.202503975 · Cited by 21
Abdelrahman, M. A., Eldehna, W. M., Nocentini, A., Ibrahim, H. S., Almahli, H., Abdel‐Aziz, H. A., Abou‐Seri, S. M., & Supuran, C. T. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1697250 · Cited by 21
Helwa, A. A., Gedawy, E. M., Taher, A. T., El-Ansary, A. K. E., & Abou‐Seri, S. M. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0146 · Cited by 21
Pan-Cancer Prediction of Cell-Line Drug Sensitivity Using Network-Based Methods
Pouryahya, M., Oh, J. H., Mathews, J. C., Belkhatir, Z., Moosmüller, C., Deasy, J. O., & Tannenbaum, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031074 · Cited by 23
Ahmed, R. F., Mahmoud, W. R., Abdelgawad, N. M., Fouad, M. A., & Said, M. F. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115805 · Cited by 21
Abdelhamed, A. M., Hassan, R. A., Kadry, H. H., & Helwa, A. A. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00476g · Cited by 21
Mansour, M. A., AboulMagd, A. M., Abbas, S. H., Abdel‐Aziz, M., & Abdel-Rahman, H. M. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202300626 · Cited by 22
Synthesis and Cytotoxicity of Novel Hexahydrothienocycloheptapyridazinone Derivatives
Pau, A., Murineddu, G., Asproni, B., Murruzzu, C., Grella, G. E., Pinna, G. A., Curzu, M. M., Marchesi, I., & Bagella, L. (2009) · Molecules · doi:10.3390/molecules14093494 · Cited by 21
Gangjee, A., Zhao, Y., Hamel, E., Westbrook, C., & Mooberry, S. L. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2007722 · Cited by 21
Synthesis and cytotoxicity of triterpene seven-membered cyclic amines
Kazakova, O. B., Giniyatullina, G. V., Medvedeva, N. I., Lopatina, T. V., Байкова, И. П., Толстиков, Г. А., & Николаевна, А. Г. (2014) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s106816201402006x · Cited by 21
Synthesis and cytotoxicity of allobetulin derivatives
Kazakova, O. B., Smirnova, I. E., Khusnutdinova, E. F., Zhukova, O. S., Фетисова, Л. В., Николаевна, А. Г., Medvedeva, N. I., Yamansarov, E. Y., Байкова, И. П., Nguyen, T. T., et al. (2014) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162014050082 · Cited by 21
Eurtivong, C., Reynisdóttir, I., Kuczma, S., Furkert, D. P., Brimble, M. A., & Reynisson, J. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.061 · Cited by 21
Succinamide derivatives of melampomagnolide B and their anti-cancer activities
Janganati, V., Ponder, J., Thakkar, S., Jordan, C. T., & Crooks, P. A. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.05.008 · Cited by 21
Szafrański, K., Slawinski, J. J., Kędzia, A., & Kwapisz, E. (2017) · Molecules · doi:10.3390/molecules22111926 · Cited by 23
Zafar, A., Pilkington, L. I., Haverkate, N. A., van Rensburg, M., Leung, E. Y., Kumara, S., Denny, W. A., Barker, D. L. A., Alsuraifi, A., Hoskins, C., et al. (2018) · Molecules · doi:10.3390/molecules23010145 · Cited by 23
Metadata
- Authors
- Boyd, M. R., & Paull, K. D.
- Affiliations
- Frederick National Laboratory for Cancer Research (US)
- National Cancer Institute (US)
- Corresponding author
- Boyd, Michael R.
- ORCID
- Boyd, Michael R.
- Venue
- Drug Development Research
- Publisher
- Wiley
- Published
- 1995-02
- Volume
- 34
- Issue
- 2
- Pages
- 91-109
- ISSN
- 0272-4391 (ISSN-L)
- 1098-2299
- OpenAlex
- W2118909720
- Cited by
- 1,572
- References
- 40
- Citations by year
- 2026: 28 · 2025: 57 · 2024: 79 · 2023: 58 · 2022: 68 · 2021: 81 · 2020: 74 · 2019: 51 · 2018: 58 · 2017: 39 · 2016: 56 · 2015: 61 · 2014: 78 · 2013: 84 · 2012: 79
- FWCI
- 30.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Development Research (publishedVersion, public-domain)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- anticancer drug discovery, human cancer cell lines, anticancer activity, lead compound identification, mechanism of action
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.